ProAxsis Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ProAxsis Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12123
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases in complex biological samples with a high level of specificity and selectivity. Its active neutrophil elastase immunoassay is also used to predict future risk of aggravation in bronchiectasis. ProAxsis also provide biomarker services, clinical trial and pharma services, and academic support services. The company provides peptide-based inhibitor design and synthesis, activity-based steady state assays, ELISAs and enzyme kinetics and compound characterization, among others. Its products is used for detection and measurement of active protease biomarkers of disease. ProAxsis is headquartered in Belfast, the UK.

ProAxsis Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ProAxsis Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ProAxsis Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ProAxsis Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ProAxsis Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ProAxsis Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ProAxsis Ltd, Medical Equipment, Deal Details 10
Partnerships 10
ProAxsis Enters into Licensing Agreement with Queen’s University 10
ProAxsis Enters into Agreement with US Biotechnology Company 11
Acquisition 12
NetScientific Acquires Majority Stake in ProAxsis 12
ProAxsis Ltd – Key Competitors 13
ProAxsis Ltd – Key Employees 14
ProAxsis Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Product News 16
Sep 06, 2017: ProAxsis abstracts at 2017 European Respiratory Society Conference 16
May 05, 2017: ProAxsis abstracts at 2017 American Thoracic Society Conference 17
Other Significant Developments 18
Jun 01, 2018: ProAxsis Awarded Invest NI Grant for Development of New ProteaseTag Products 18
Jan 16, 2018: NetScientific Portfolio Update 19
Nov 21, 2017: ProAxsis provides update on commercialisation progress 20
Oct 27, 2017: ProAxsis to test ProteaseTag Technology in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease at National Jewish Health 21
Sep 11, 2017: ProAxsis signs partnership with a large US based biotechnology company 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
ProAxsis Ltd, Medical Equipment, Key Facts, 2017 2
ProAxsis Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ProAxsis Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ProAxsis Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ProAxsis Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ProAxsis Ltd, Deals By Market, 2012 to YTD 2018 8
ProAxsis Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ProAxsis Enters into Licensing Agreement with Queen’s University 10
ProAxsis Enters into Agreement with US Biotechnology Company 11
NetScientific Acquires Majority Stake in ProAxsis 12
ProAxsis Ltd, Key Competitors 13
ProAxsis Ltd, Key Employees 14
ProAxsis Ltd, Subsidiaries 15

List of Figures
ProAxsis Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ProAxsis Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ProAxsis Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ProAxsis Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ProAxsis Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ProAxsis Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ProAxsis Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ProAxsis Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ProAxsis Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gothaer Asigurari Reasigurari S.A.:企業の戦略・SWOT・財務情報
    Gothaer Asigurari Reasigurari S.A. - Strategy, SWOT and Corporate Finance Report Summary Gothaer Asigurari Reasigurari S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Societatea Nationala Nuclearelectrica SA (SNN):企業の財務・戦略的SWOT分析
    Societatea Nationala Nuclearelectrica SA (SNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Bharat Road Network Ltd (BRNL):企業の財務・戦略的SWOT分析
    Bharat Road Network Ltd (BRNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Immupharma Plc (IMM):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmuPharma Plc (ImmuPharma) develops novel drugs for the treatment of serious medical conditions with unmet medical need. ImmuPharma develops drugs for the treatment of lupus, cancer, moderate to severe pain, highly resistant hospital-acquired infections such as methicillin-resistant staphyl …
  • Jardine Engineering Corporation, Limited:企業の戦略・SWOT・財務情報
    Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report Summary Jardine Engineering Corporation, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Pharmstandard:企業の戦略的SWOT分析
    Pharmstandard - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • InMed Pharmaceuticals Inc (IN):企業の財務・戦略的SWOT分析
    Summary InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based medicines. The company's pipeline products include INM-750, INM-405, and INM-085. Its products finds applicati …
  • Fortinet Inc (FTNT):企業の財務・戦略的SWOT分析
    Fortinet Inc (FTNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Teachers Mutual Bank Limited:企業の戦略的SWOT分析
    Teachers Mutual Bank Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Actuant Corporation:企業の戦略・SWOT・財務情報
    Actuant Corporation - Strategy, SWOT and Corporate Finance Report Summary Actuant Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Zweites Deutsches Fernsehen:企業の戦略的SWOT分析
    Zweites Deutsches Fernsehen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • CARE Super Pty Ltd:企業の戦略・SWOT・財務分析
    CARE Super Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary CARE Super Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • aTyr Pharma Inc (LIFE):企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • Bell Food Group Ltd:戦略・SWOT・企業財務分析
    Bell Food Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Bell Food Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bumi Armada Berhad (ARMADA):石油・ガス:M&Aディール及び事業提携情報
    Summary Bumi Armada Bhd (Bumi Armada) is an integrated offshore solutions provider. The company owns and operates Floating Production Storage & Offloading (FPSO), Offshore Support Vessels (OSV), pipelaying barges, and subsea vessels. Its FPSO portfolio includes Armada TGT 1, Armada Sterling, Armada …
  • Peyto Exploration & Development Corp (PEY):企業の財務・戦略的SWOT分析
    Summary Peyto Exploration & Development Corp (Peyto Exploration & Development) is an oil and gas exploration and development company that acquires, explores, develops and produces crude oil and unconventional natural gas reserves. The company operates the Alberta Deep Basin, a geologic setting locat …
  • Velvet Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Velvet Energy Ltd (Velvet Energy) is an oil and gas exploration company that explores and develops oil and liquid-rich natural gas from its assets. The company’s exploration and development operation assets are located in Deep Basin in West-Central Alberta. It produces 17,000 barrels of oil …
  • Omron Healthcare Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Omron Healthcare Co Ltd (Omron Healthcare), a subsidiary of Omron Corp, is a provider of medical equipment for health monitoring and therapy. The company offers blood pressure monitors, digital thermometers, body fat meters, pedometers, nebulizers, body composition monitors and electric toot …
  • PerkinElmer Inc (PKI):企業の製品パイプライン分析
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services. The company’s major products include cytogenetics reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆